LBEPB14 Epidemiological and clinical features of mpox in adults aged greater than 50 years in the United States of America, May 2022–April 2023E-posterHIV and ageing
LBEPB15 Neural tube defects and major external structural abnormalities by antiretroviral treatment regimen in Botswana: 2014-2022E-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
LBEPB16 HIV drug resistance profile in clients experiencing treatment failure after the transition to a dolutegravir-based, first-line antiretroviral treatment regimen in MozambiqueE-posterART resistance
LBEPB17 Analytical treatment interruption among African women and Peruvian men & transgender individuals with early ART initiation +/- VRC01 circulating at HIV acquisition: early observations of viral rebound & controlE-posterOther strategies and therapies
LBEPB18 Anti-PD-L1 antibody ASC22 in combination with chidamide potentiates HIV latency reversal and immune function from ART-suppressed individuals: a single center, single-arm, phase 2 studyE-posterOther strategies and therapies
LBEPB19 Factors associated with COVID-19 vaccination uptake amongst PLHIV in southern NigeriaE-posterSARS-CoV-2, COVID-19 and HIV
LBEPB20 T-cell responses induced by HTI vaccines and vesatolimod correlate with improved control of HIV reboundE-posterOther strategies and therapies
LBEPC21 HIV transmission clusters in Zambia are smaller than in Europe: evidence from the HPTN-071 (PopART) study, BEEHIVE study, and individual-based modelsE-posterSurveillance: Measuring the HIV epidemic
LBEPC22 Preliminary results of the bio behavioral survey among prisoners in MozambiqueE-posterSurveillance: Measuring the HIV epidemic
LBEPC23 Relative risk of death during pre-Delta, Delta and Omicron variants waves among children and adults hospitalized with COVID-19 in AfricaE-posterEpidemiology of COVID-19
1151 - 1160 of 1427 items